APA (7th ed.) Citation

Kind, A. B., Pavelyev, A., Kothari, S., El Mouaddin, N., Schmidt, A., Morais, E., . . . Lienert, F. (2020). Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland. BMC public health, 20(1), 671-13. https://doi.org/10.1186/s12889-020-08840-0

Chicago Style (17th ed.) Citation

Kind, André B., Andrew Pavelyev, Smita Kothari, Nadia El Mouaddin, Aurélie Schmidt, Edith Morais, Patrik Guggisberg, and Florian Lienert. "Assessing the Epidemiological Impact on Cervical Cancer of Switching from 4-valent to 9-valent HPV Vaccine Within a Gender-neutral Vaccination Programme in Switzerland." BMC Public Health 20, no. 1 (2020): 671-13. https://doi.org/10.1186/s12889-020-08840-0.

MLA (9th ed.) Citation

Kind, André B., et al. "Assessing the Epidemiological Impact on Cervical Cancer of Switching from 4-valent to 9-valent HPV Vaccine Within a Gender-neutral Vaccination Programme in Switzerland." BMC Public Health, vol. 20, no. 1, 2020, pp. 671-13, https://doi.org/10.1186/s12889-020-08840-0.